Healthcare | June 22, 2023
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
These re-agent and diagnostic test kits come with 99.7% accuracy
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Getinge has a strong market share in India within several product segments
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
Technology Development Board supports commercialisation of Metal Injection Molding of implants
The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research
Subscribe To Our Newsletter & Stay Updated
